212 related articles for article (PubMed ID: 33687706)
1. Clinical Proteomics for the Analysis of Circulating Extracellular Vesicles.
Barrachina MN; García Á
Methods Mol Biol; 2021; 2259():13-23. PubMed ID: 33687706
[TBL] [Abstract][Full Text] [Related]
2. A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients.
Barrachina MN; Sueiro AM; Casas V; Izquierdo I; Hermida-Nogueira L; Guitián E; Casanueva FF; Abián J; Carrascal M; Pardo M; García Á
Proteomics; 2019 Jan; 19(1-2):e1800248. PubMed ID: 30536591
[TBL] [Abstract][Full Text] [Related]
3. 2D gel electrophoresis and mass spectrometry identification and analysis of proteins.
Meleady P
Methods Mol Biol; 2011; 784():123-37. PubMed ID: 21898217
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
5. Rapid Isolation of Extracellular Vesicles from Blood Plasma with Size-Exclusion Chromatography Followed by Mass Spectrometry-Based Proteomic Profiling.
Kreimer S; Ivanov AR
Methods Mol Biol; 2017; 1660():295-302. PubMed ID: 28828666
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry of extracellular vesicles.
Pocsfalvi G; Stanly C; Vilasi A; Fiume I; Capasso G; Turiák L; Buzas EI; Vékey K
Mass Spectrom Rev; 2016; 35(1):3-21. PubMed ID: 25705034
[TBL] [Abstract][Full Text] [Related]
7. Top-Down Proteomics and Comparative 2D-DIGE Analysis.
Ohlendieck K
Methods Mol Biol; 2023; 2596():19-38. PubMed ID: 36378428
[TBL] [Abstract][Full Text] [Related]
8. A size-exclusion-based approach for purifying extracellular vesicles from human plasma.
Vanderboom PM; Dasari S; Ruegsegger GN; Pataky MW; Lucien F; Heppelmann CJ; Lanza IR; Nair KS
Cell Rep Methods; 2021 Jul; 1(3):. PubMed ID: 34355211
[TBL] [Abstract][Full Text] [Related]
9. Depletion of abundant plasma proteins for extracellular vesicle proteome characterization: benefits and pitfalls.
Reymond S; Gruaz L; Sanchez JC
Anal Bioanal Chem; 2023 Jul; 415(16):3177-3187. PubMed ID: 37069444
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Toolbox To Standardize the Separation of Extracellular Vesicles and Lipoprotein Particles.
Wang T; Turko IV
J Proteome Res; 2018 Sep; 17(9):3104-3113. PubMed ID: 30080417
[TBL] [Abstract][Full Text] [Related]
11. Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics.
Kreimer S; Belov AM; Ghiran I; Murthy SK; Frank DA; Ivanov AR
J Proteome Res; 2015 Jun; 14(6):2367-84. PubMed ID: 25927954
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Size Exclusion Chromatography for Extracellular Vesicle Enrichment and Proteomic Analysis from Clinically Relevant Samples.
Lane RE; Korbie D; Trau M; Hill MM
Proteomics; 2019 Apr; 19(8):e1800156. PubMed ID: 30632691
[TBL] [Abstract][Full Text] [Related]
13. DIGE-Based Biomarker Discovery in Blood Cancers.
Dunphy K; Dowling P
Methods Mol Biol; 2023; 2596():105-112. PubMed ID: 36378434
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles.
Munshi A; Mehic J; Creskey M; Gobin J; Gao J; Rigg E; Muradia G; Luebbert CC; Westwood C; Stalker A; Allan DS; Johnston MJW; Cyr T; Rosu-Myles M; Lavoie JR
Stem Cell Res Ther; 2019 Dec; 10(1):401. PubMed ID: 31852509
[TBL] [Abstract][Full Text] [Related]
15. An Update on Isolation Methods for Proteomic Studies of Extracellular Vesicles in Biofluids.
Li J; He X; Deng Y; Yang C
Molecules; 2019 Sep; 24(19):. PubMed ID: 31569778
[TBL] [Abstract][Full Text] [Related]
16. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE).
Kondo T
Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):2-8. PubMed ID: 30392560
[TBL] [Abstract][Full Text] [Related]
17. Plasma/Serum Proteomics based on Mass Spectrometry.
Zhu Y
Protein Pept Lett; 2024; 31(3):192-208. PubMed ID: 38869039
[TBL] [Abstract][Full Text] [Related]
18. Analysis of proteins using DIGE and MALDI mass spectrometry.
Winnik WM; Dekroon RM; Jeong JS; Mocanu M; Robinette JB; Osorio C; Dicheva NN; Hamlett E; Alzate O
Methods Mol Biol; 2012; 854():47-66. PubMed ID: 22311753
[TBL] [Abstract][Full Text] [Related]
19. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
[TBL] [Abstract][Full Text] [Related]
20. Identification of Subproteomic Markers for Skeletal Muscle Profiling.
Dowling P; Gargan S; Swandulla D; Ohlendieck K
Methods Mol Biol; 2023; 2596():291-302. PubMed ID: 36378446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
